Induction of CMV-specific T-cell lines using Ag-presenting cells pulsed with CMV protein or peptide

By Einsele H   Rauser G   Grigoleit U   Hebart H   Sinzger C   Riegler S   Jahn G  

Cytotherapy, Vol. 4, Iss. 1, 2002-01 ,pp. : 49-54

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Detailed analysis of cytomegalovirus (CMV)-specific T cells expanded for adoptive immunotherapy of CMV infection following allogeneic stem cell transplantation for malignant disease

By Hobeika Ac   Osada T.   Serra D.   Peplinski S.   Hanson K.   Tanaka Y.   Niedzwiecki D.   Chao N.   Rizzieri D.   Lyerly Hk   Clay T.   Morse Ma  

Cytotherapy, Vol. 10, Iss. 3, 2008-01 ,pp. : 289-302

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Expansion of human CMV-specific cytotoxic T lymphocytes to a clinical scale: a simple culture system using tetrameric HLA-peptide complexes

By Watanabe N   Kamachi Y   Koyama N   Hama A   Liang J   Nakamura Y   Yamamoto T   Isomura M   Kudo K   Kuzushima K   Kojima S  

Cytotherapy, Vol. 6, Iss. 5, 2004-10 ,pp. : 514-522

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Preparing clinical grade Ag-specific T cells for adoptive immunotherapy trials

By Digiusto Dl   Cooper Ljn  

Cytotherapy, Vol. 9, Iss. 7, 2007-01 ,pp. : 613-629

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Adoptive transfer of Ag-specific T cells to prevent CMV disease after allogeneic stem-cell transplantation

By van Rhee F   Barrett J  

Cytotherapy, Vol. 4, Iss. 1, 2002-01 ,pp. : 3-10

Ashgate Publishing Ltd

Access to resources Recommend Favorite